BIOGEN INC. Total Liabilities 2008-2026 | BIIB
Beta
What is total liabilities?
Total liabilities can be defined as the sum of all current and non-current debts and obligations owed by the company.
What is BIOGEN INC.'s current total liabilities?
BIOGEN INC. (BIIB) annual total liabilities for 2025 was $11.18B, a 1.33% decline from 2024. BIOGEN INC. total liabilities for the quarter ending March 31, 2026 was $10.83B.
What was BIOGEN INC.'s total liabilities in 2024?
BIOGEN INC. annual total liabilities for 2024 was $11.33B, a 5.91% decline from 2023.
What was BIOGEN INC.'s total liabilities in 2023?
BIOGEN INC. annual total liabilities for 2023 was $12.05B, a 7.88% increase from 2022.
What is BIOGEN INC.'s 5-year total liabilities CAGR?
BIOGEN INC. total liabilities grew at a compound annual growth rate (CAGR) of 4.30% from FY2020 to FY2025, going from $13.93B to $11.18B over 5 years.
Total Liabilities History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR-4.3%
FY2020
$13.93B
→
FY2025
$11.18B
080910111213141516171819202122232425
5 years selected
Total Liabilities History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $11.18B | -1.3% | 10-K |
| FY2024 | $11.33B | -5.9% | 10-K |
| FY2023 | $12.05B | +7.9% | 10-K |
| FY2022 | $11.17B | -13.6% | 10-K |
| FY2021 | $12.92B | -7.3% | 10-K |
| FY2020 | $13.93B | +0.3% | 10-K |
| FY2019 | $13.90B | +13.4% | 10-K |
| FY2018 | $12.26B | +10.9% | 10-K |
| FY2017 | $11.05B | +2.8% | 10-K |
| FY2016 | $10.75B | +6.1% | 10-K |
| FY2015 | $10.13B | +189.4% | 10-K |
| FY2014 | $3.50B | +8.0% | 10-K |
| FY2013 | $3.24B | +2.4% | 10-K |
| FY2012 | $3.17B | +20.7% | 10-K |
| FY2011 | $2.62B | -0.8% | 10-K |
| FY2010 | $2.64B | +15.4% | 10-K |
| FY2009 | $2.29B | -13.4% | 10-K |
| FY2008 | $2.65B | - | 10-K |
Company: BIOGEN INC.Ticker: BIIBSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →